VGYAAN PHARMACEUTICALS
VGYAAN Pharmaceuticals specializes in developing and commercializing clinically critical therapies across a variety of categories.
VGYAAN PHARMACEUTICALS
Industry:
Chemical Engineering Pharmaceutical
Founded:
2015-01-01
Address:
Skillman, New Jersey, United States
Country:
United States
Website Url:
http://www.vgyaan.com
Total Employee:
1+
Status:
Active
Contact:
+1 609-452-2770
Similar Organizations
AFJ Pharmaceuticals
AFJ Pharmaceuticals specializes in developing and commercializing generic drugs.
Andarix Pharmaceuticals
Andarix Pharmaceuticals is developing and commercializing novel cancer therapies that are targeted to the patients most likely to respond.
Eleison Pharmaceuticals
Eleison Pharmaceuticals acquires, develops, and commercializes clinical stage drug candidates for "orphan" cancers.
Gemin X Pharmaceuticals
Gemin X Pharmaceuticals develops and commercializes targeted cancer therapeutics to improve the lives of patients.
Valcrest Pharmaceuticals
Valcrest Pharmaceuticals specializes in the development and commercialization of novel pharmaceutical products.
Current Employees Featured
Founder
Official Site Inspections
http://www.vgyaan.com Semrush global rank: 13.03 M Semrush visits lastest month: 78
- Host name: 49.227.109.208.host.secureserver.net
- IP address: 208.109.227.49
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260

More informations about "VGYAAN Pharmaceuticals"
About - VGYAAN
VGYAAN Pharmaceuticals LLC is a privately held specialty pharmaceutical company focused on developing and commercializing clinically critical therapies across a variety of dosage forms and therapeutic categories, including โฆSee details»
VGYAAN Pharmaceuticals US Based Specialty Pharmaceutical โฆ
VGYAAN Pharmaceuticals has been acquired by RK Pharma Inc. Focused on Developing and Commercializing Clinically Critical TherapiesSee details»
VGYAAN Pharmaceuticals - Crunchbase Company โฆ
VGYAAN Pharmaceuticals is located in Skillman, New Jersey, United States. Who are VGYAAN Pharmaceuticals 's competitors? Alternatives and possible โฆSee details»
VGYAAN Pharmaceuticals LLC: Contact Details and Business Profile
VGYAAN Pharmaceuticals, LLC is a privately held specialty pharmaceutical company concentrated on developing and commercializing clinically critical therapies across a variety of โฆSee details»
VGYAAN Pharmaceuticals - Overview, News & Similar companies
Jun 14, 2023 Who is VGYAAN Pharmaceuticals. VGYAAN Pharmaceuticals, LLC is a privately held specialty pharmaceutical company concentrated on developing and commercializing โฆSee details»
Vgyaan Pharmaceuticals LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Vgyaan Pharmaceuticals LLC of Skillman, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Vgyaan Pharmaceuticals - Products, Competitors, Financials, โฆ
Vgyaan Pharmaceuticals engages in the development and commercializing of clinically critical therapies across a variety of dosage forms and therapeutic categories, including generics and โฆSee details»
Careers - VGYAAN
Our industry is going through a metamorphosis on many levels, and we believe that VGYAAN can contribute positively to the changing landscape. We know that it takes a team with a diverse โฆSee details»
R K Pharma acquires VGYAAN Pharmaceuticals - Crunchbase
R K Pharma acquires VGYAAN Pharmaceuticals on 2023-06-15 for an undisclosed amount. Search Crunchbase. Start Free Trial . Chrome Extension. ... Save . Summary. Overview. Edit โฆSee details»
VGYAAN Pharmaceuticals - Contacts, Employees, Board Members, โฆ
Organization. VGYAAN Pharmaceuticals . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. About. โฆSee details»
Premier Joint Venture with VGYAAN Pharmaceuticals โฆ
Dec 7, 2021 Today Premier is announcing the launch of the first drug developed through its existing partnership with VGYAAN Pharmaceuticals LLC.The first product under this partnership is an injectable medication used in a variety of โฆSee details»
RK Pharma Completes Acquisition of VGYAAN Pharmaceuticals
VGYAAN Pharmaceuticals. โWith RK Pharmaโs robust capabilities in complex product development, state-of-the-art manufacturing capabilities of APIs and finished dosages, vertical โฆSee details»
Vgyaan - Overview, News & Similar companies | ZoomInfo.com
Who is Vgyaan. Founded in 2017, VGYAAN is a leading developer and manufacturer of smart classroom and visual collaboration solutions. With a large portfolio of pr oducts ranging from โฆSee details»
RK Pharma Completes Acquisition of VGYAAN Pharmaceuticals
Jun 16, 2023 RK Pharma Inc, a vertically integrated pharmaceutical company today announced the successful completion of the acquisition of VGYAAN Pharmaceuticals LLC. โThe โฆSee details»
VGYAAN Corporate Video - YouTube
VGYAAN Corporate videoIntroducing Vgyaan: Bridging the Gap in Education with Affordable TechnologyHi everyone, I'm the founder and managing director at Vgyaa...See details»
Vgyaan - Facebook
Vgyaan. 58 likes. Keeping the student at the centre of our vision at VGyaan we have built a team of highly quali ed, experienced and more importantly dedicated team of teaching professionals โฆSee details»
Home - vgyaan
Vgyaan Classroom Solutions has transformed our learning environment. The interactive whiteboards and digital content have made lessons more engaging for our students. The โฆSee details»
Partners - VGYAAN
The genesis of our company is from collaboration, therefore, we truly believe in partnering with a wide range of companies including R&D organizations, API manufacturers, contract โฆSee details»
pc-chasis - vgyaan
Accommodates i3/i5/i7 specs, offering ample space for PC, UPS, keyboard, and mouse, optimizing organization and efficiency. Know More. PC Chasis. Model No: VGPC-AD760. โฆSee details»
Products - VGYAAN
At VGYAAN Pharmaceuticals, we are focused on developing and commercializing drug therapies across a variety of dosage forms and therapeutic categories. Currently, our product portfolio โฆSee details»